Medical News

RSS

ALMA launches malaria drive on opening day of WEF on Africa

The African Leaders Malaria Alliance, comprised of the heads of 26 countries, on Wednesday at the World Economic Forum (WEF) on Africa "launched a fresh drive to eliminate malaria using a combination of bed nets, insecticides and medication," Reuters reports (Nyambura-Mwaura, 5/5).

7 May 2010

Pennsylvania Auditor assails use of some HIV/AIDS prevention funds

Philadelphia Inquirer: "The Pennsylvania Auditor General's Office criticized the state's oversight of HIV/AIDS prevention funding Wednesday in a report that alleges more than $700,000 in waste, abuse, and potentially fraudulent spending by the Philadelphia Department of Public Health.

7 May 2010

Accuray reports total revenue of $51.9M in third quarter 2010

Accuray Incorporated, a global leader in the field of radiosurgery, announced today financial results for the third quarter of fiscal year 2010, ended March 31, 2010.

7 May 2010

ImmunoGen prices common stock public offering at $8.00 per share

ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, announced today that it has priced a public offering of 9,000,000 shares of its common stock at a price of $8.00 per share.

7 May 2010

Hospitals criticized for keeping quiet on charity care

Kaiser Health News staff writer Julie Appleby writes: "Too many nonprofit hospitals fail to adequately publicize their charity-care programs, two advocacy groups say in a survey report released today"

7 May 2010

WHO publishes comprehensive report on H1N1

"A year after the H1N1 [swine] flu first appeared, the World Health Organization has issued perhaps the most comprehensive report on the pandemic's activity to date," HealthDay News/Bloomberg BusinessWeek reports (Gardner, 5/5).

7 May 2010

IASIS Healthcare second-quarter net revenue up 7.9% to $624.5 million

IASIS Healthcare® LLC today announced financial and operating results for the fiscal second quarter and six months ended March 31, 2010.

7 May 2010

FDA approves new oral contraceptive Natazia

The U.S. Food and Drug Administration today approved Natazia, a combination hormonal tablet for use as an oral contraceptive.

7 May 2010

Massachusetts Attorney General pledges hearings into proposed Catholic Hospitals sale

The Associated Press/Boston Herald: Massachusetts Attorney General Martha Coakley is pledging to hold public hearings on a proposed sale of a chain of Catholic Hospitals there to a private equity firm. "Coakley said Caritas Christi Health System today filed a formal notice of the proposed transfer of the system to Steward Health Care System LLC, an affiliate of New York-based Cerberus Capital Management."

7 May 2010

Bioengineers define relationship between key regulatory proteins

With thousands of scientists across the globe searching for ways to use adult stem cells to fight disease, there's a growing emphasis on finding the "master regulators" that guide the differentiation of stem cells. New research from Rice University and the University of Cambridge suggests that a closely connected trio of regulatory proteins fulfills that role in hematopoietic stem cells (HSCs), the self-renewing cells the body uses to make new blood cells.

7 May 2010

Doctors seeing patients in groups

The Denver Post: "Jeff Wilson saw a doctor recently about his high cholesterol — and five other patients with the same problem came to his appointment. It was a 'group visit,' a growing trend in health care that allows doctors to reach more patients and patients to get more face time with their physician, even if they have to share it."

7 May 2010

Oramed reports Phase 2b non-FDA clinical trial results of ORMD-0801 oral insulin capsule

Oramed Pharmaceuticals Inc., a developer of alternative drug delivery systems, reported today results for the recently completed Phase 2b non-FDA clinical trial of its flagship oral insulin capsule, ORMD-0801.

7 May 2010

Vitamin A supplements shown not to reduce maternal mortality

A new trial undertaken in Ghana has shown that vitamin A supplements do not reduce maternal mortality-contradicting previous findings from a trial in Nepal which showed a 44% decrease.

6 May 2010

Darwin may have lost his own children due to ill effects of inbreeding

Charles Darwin whose theories on evolution have been the basis of all that we know about the evolution of mankind and genetics may have lost his own progeny to inbreeding says a new study.

6 May 2010

Fart blanket here to make marriages better!

A blanket made of activated carbon fragment that can aid in absorbing the stench from flatulence has been a hit in the market. The advertisement has become a hit on Youtube. MyFOXny.com said that this campaign for a Better Marriage Blanket is still not on TV but has been viewed more than one million times online since March 31. Another online marketing site has also called it “this year's Snuggie”.

6 May 2010

Chicken nuggets rate not too good in nutritional value: consumer report

A product evaluation organization Consumer Reports recently analyzed 12 brands of chicken nuggets including brands like Market Pantry (from Target), Bell & Evans Breaded, Kirland Signature Disney (Costco), and Health Is Wealth.

6 May 2010

Australia’s first ever health policy for men

Prime Minister Kevin Rudd yesterday announced Australia’s first ever men’s health policy called the “National Male Health Policy”. He said in the announcement during a visit to the Whittlesea Men's Shed in Victoria, “They either think that they're invincible that they can just tough it out…'They don't like talking about it usually, and frankly, the problem with all that is it makes it really hard to deal with men's health problems before they become too serious.” He felt this move was long due. He added, “'It's a pretty important time that we do that, we're probably about 110 years late.”

6 May 2010

Keryx Biopharmaceuticals commences Phase 3 registration program for Zerenex

Keryx Biopharmaceuticals, Inc. announced today the initiation of its short-term Phase 3 study of Zerenex™ (ferric citrate), the Company's iron-based phosphate binder for the treatment of elevated serum phosphorous levels, or hyperphosphatemia, in patients with end-stage renal disease on dialysis.

6 May 2010

Abraxis Bioscience first-quarter ABRAXANE revenue increases to $87.9 million

Abraxis BioScience, Inc., a fully integrated biotechnology company, today reported unaudited financial results for the first quarter ended March 31, 2010.

6 May 2010

SCOLR Pharma grants RedHill worldwide rights to market and sell CDT-based ondansetron

SCOLR Pharma, Inc. today announced that it has executed a Licensing Agreement with RedHill Biopharma Ltd. an Israeli corporation, (RedHill), granting RedHill the worldwide rights to market and sell ondansetron tablet formulations based on SCOLR's proprietary extended delivery technology (CDT). Ondansetron hydrochloride is the active ingredient in Zofran®, GlaxoSmithKline's drug to prevent chemotherapy and radiation related nausea and vomiting.

6 May 2010